SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001171843-19-005356
Filing Date
2019-08-08
Accepted
2019-08-08 20:57:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4838
2 GRAPHIC logo.jpg GRAPHIC 4331
  Complete submission text file 0001171843-19-005356.txt   11821
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations